Template:Sympatholytic antihypertensives: Difference between revisions
From WikiMD's Wellness Encyclopedia
m 1 revision imported |
en>Jonesey95 m Fix text color in dark mode; this generally works but may cause problems, in which case revert or try specifying a different CSS value |
||
| Line 101: | Line 101: | ||
| group2 = [[Endothelin receptor antagonist]]s (for {{Abbrlink|PH|Pulmonary hypertension}}) | | group2 = [[Endothelin receptor antagonist]]s (for {{Abbrlink|PH|Pulmonary hypertension}}) | ||
| list2 = | | list2 = | ||
* ''dual'' ([[Aprocitentan]], [[Bosentan]], [[Macitentan]] ([[Macitentan/tadalafil|+tadalafil]])) | * ''dual'' ([[Aprocitentan]], [[Bosentan]], [[Macitentan]] ([[Macitentan/tadalafil|+tadalafil]]), [[Riociguat]]) | ||
* ''selective'' ([[Ambrisentan]], [[Sitaxentan]]) | * ''selective'' ([[Ambrisentan]] ([[Ambrisentan/tadalafil|+tadalafil]]), [[Sitaxentan]], [[Sotatercept]]) | ||
}} | }} | ||
| belowstyle = | | belowstyle = padding: 0px; | ||
| below = {{PharmNavFootnote}} | | below = {{PharmNavFootnote}} | ||
}} <noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Drug templates by ATC]] | [[Category:Drug templates by ATC]] | ||
</noinclude> | </noinclude> | ||
Revision as of 17:18, 3 February 2025
| Sympatholytic (and closely related) antihypertensives (C02) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
